Fidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian Outcomes

Table 2

Distribution of patients with BI and non-BI strains by region and hospitalization status at time of randomization.

	BI strain	Non-BI strain	Total
Region
Quebec, number (%)	84 (48.3)	90 (51.7)	174
Ontario, number (%)	33 (58.9)	23 (41.1)	56
West (BC, AB, and SK), number (%)	16 (14.3)	96 (85.7)	112
Hospitalization status
Inpatient, number (%)	107 (62.9)	63 (37.1)	170
Outpatient, number (%)	26 (15.1)	146 (84.9)	172

AB, Alberta; BC, British Columbia; BI, BI/NAP1/027; SK, Saskatchewan.